Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)

Journal article published in 2022 by Xiaobin Shang, Gang Zhao, Fei Liang , Chen Zhang, Weihong Zhang, Liang Liu, Runmei Li, Xiaofeng Duan, Zhao Ma, Jie Yue, Chuangui Chen, Bin Meng, Xiubao Ren, Hongjing Jiang

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by